Irreversible binding inhibitors

Inhibitors are molecnles which decrease the activity of the enzymes and can be divided in two classes reversible binding inhibitors and irreversible binding inhibitors. 

To develop safer drugs, it is important to identify irreversible CYP inhibitors at an early stage in the drug discovery process. Certain substructures, reviewed in this chapter, are frequently responsible for irreversible CYP inhibition and either their use in medicinal chemistry programs should be limited or their potential for irreversible binding to CYPs should be carefully monitored. 

Novel inhibitors of glycoprotein Ilb/IIIa and fibrinogen/van WiUebrand interaction include injectable peptides (e.g. integrilin, 175) and orally active peptidomimetics that act as competitive inhibitors and a monoclonal antibody c7E3 (abciximab) that irreversibly binds to GP Ilb/ Ilia. 

The available information on the pharmacology of STS inhibitors is restricted to a few in vitro and in vivo models. From all steroidal compounds, the irreversible inhibitor EMATE was found to be the most potent STS inhibitor with an IC50 of 65 pM [ 107]. However, it has been proposed that the sulfamate moiety of EMATE irreversibly binds to the active site and releases the steroidal backbone estrone. This means that EMATE, although a potent inhibitor of STS, counteracts its own effect by releasing estrone. The most potent derivative from a series of sulfamoyloxy-substituted stilbenes inhibited the growth of MCF-7 breast cancer cells with an IC50 value of 13 nM [111]. 

The EITC-VAD-FMK in situ assay is based on the use of EITC-VAD-EMK in situ marker (Promega Corp., Wisconsin) which is an EITC conjugate of the caspase inhibitor Z-Val-Ala-Asp (OMej-CHaF (Z-VAD-EMK) which irreversibly inhibits caspase-1, -3, -4, and -7. EMK allows delivery of the inhibitor into the cell where it irreversibly binds to activated caspases (E3). The EITC label allows for a direct, one-step assay of caspase activity in living cells or tissue section. The inhibitor... 

Evidence that Epoxycreatine is an Affinity Label. All the available evidence is consistent with the hypothesis that epoxycreatine behaves like an affinity label for the enzyme and that it is attacked by a carboxylate group of the enzyme. That is, it inactivated the enzyme rapidly at 0°C. Inactivation was complete and activity did not return upon exhaustive dialysis. Creatine was shown to give protection against the inactivation in the expected manner. Most importantly, though, the irreversible binding of the Inhibitor was shown to be stoichiometric using [ Cj-epoxycrea-tine that is, one and only one inhibitor molecule becomes bound per active site, even in the presence of excess inhibitor. 

Mechanism of Action Aproton pump inhibitor that is converted to active metabolites that irreversibly bind to and inhibit hydrogen-potassium adenosine triphosphates, an enzyme on the surface of gastricparietal cells. Inhibits hydrogen ion transport into gastric lumen. Therapeutic Effect Increases gastricpH, reducing gastric acid production. 

Suicide Enzyme Inhibitors. Snicide substrates are irreversible enzyme inhibitors that bind covalently. The reactive anchoring group is catalytically activated by the enzyme itself through the enzyme-inhibitor complex. The enzyme thus produces its own inhibitor from an originally inactive compound, and is perceived to commit suicide. To design a substrate, the catalytic mechanism of the enzyme as well as the nature of the functional gronps at the enzyme active site must be known. Conversely, successful inhibition provides valuable information about the structure and mechanism of an enzyme. Componnds that form carbanions are especially usefnl in this regard. Pyridoxal phosphate-dependent enzymes form such carbanions readily becanse... 

Because the T790M mutation affects the ability of reversible TKIs to bind to EGFR, it follows that irreversible inhibitors may circumvent this problem. Irreversible EGFR inhibitors such as HKI-272, HKI-357, and a compound developed by Wyeth Research, EKB-569, have shown some early efficacy (81,91,92). These compounds form covalent bonds with the EGFR protein at a distinct cysteine residue C773, within the kinase... 

A third approach to protection against excessive acetylcholinesterase inhibition is pretreatment with reversible enzyme inhibitors to prevent binding of the irreversible organophosphate inhibitor. This prophylaxis can be achieved with pyridostigmine but is reserved for situations in which possibly lethal poisoning is anticipated, eg, chemical warfare (see Chapter 7). Simultaneous use of atropine is required to control muscarinic excess. 

However, when an irreversible inhibitor binds to the enzyme, it cannot be displaced by the substrate and thus binds irreversibly (Fig. 2—51). The irreversible type of enzyme inhibitor is sometimes called a suicide inhibitor because it covalently and irreversibly binds to the enzyme protein, permanently inhibiting it and therefore essentially killing the enzyme by making it nonfunctional forever (Fig. 2—51). Enzyme activity in this case is only restored when new enzyme molecules are synthesized. 

The original MAO inhibitors are all irreversible enzyme inhibitors, which bind to MAO irreversibly and destroy its function forever. Enzyme activity returns only after new enzyme is synthesized (see Figs. 5 — 15, 6—3 and 6—4). Sometimes such inhibitors are called suicide inhibitors because once the enzyme binds the inhibitor, the enzyme essentially commits suicide in that it can never function again until a new enzyme protein is synthesized by the neuron s DNA in the cell nucleus. 

---